Sequence Bio Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $500K

  • Investors
  • 10

Sequence Bio General Information

Description

Developer of a genome therapy designed to discover enhanced medicines and improve the treatment of a disease. The company's therapy is collaborated through the gathering of DNA and health information of unique isolated populations and is used to treat complex and inherited diseases, enabling healthcare professionals to improve the lives of the patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 53 Bond Street
  • Suite 100
  • Saint John's, Newfoundland and Labrador A1C 1S9
  • Canada
+1 (800) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sequence Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 21-Aug-2019 $500K 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 30-Jul-2019 00.000 00.000 Completed Generating Revenue
3. Seed Round 03-Aug-2016 00.00 00.00 Completed Generating Revenue
2. Seed Round 19-Oct-2015 $1M $1M Completed Generating Revenue
1. Accelerator/Incubator 01-Aug-2015 Completed Generating Revenue
To view Sequence Bio’s complete valuation and funding history, request access »

Sequence Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a genome therapy designed to discover enhanced medicines and improve the treatment of a disease. The compan
Biotechnology
Saint John's, Canada
20 As of 2023
00.000
0.000 0000-00-00
000000000000 00.000

000000

lor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut l
0000 000000000
New York, NY
00 As of 0000
00000
0000 0000-00-00
00000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sequence Bio Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY 00 00000 00000000000 00000
You’re viewing 1 of 1 competitors. Get the full list »

Sequence Bio Executive Team (12)

Name Title Board Seat Contact Info
Chris Gardner Co-Founder, Co-Chief Executive Officer, President, Board Member & Strategic Adviser
Lynn Healey Co-Chief Executive Officer, Chief Financial Officer & Chief Operating Officer
Dave Phillips Director of Finance & Administration
You’re viewing 3 of 12 executive team members. Get the full list »

Sequence Bio Board Members (8)

Name Representing Role Since
Brendan Paddick Self Board Member 000 0000
Chris Gardner Sequence Bio Co-Founder, Co-Chief Executive Officer, President, Board Member & Strategic Adviser 000 0000
Chris Moyer Pelorus Venture Capital Board Member 000 0000
James Hardiman DCVC Board Member 000 0000
John Phillips Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Sequence Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sequence Bio Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Y Combinator Accelerator/Incubator 000 0000 000000 0
C3 Ventures (VC) Venture Capital Minority 000 0000 000000 0
HOF Capital Venture Capital Minority 000 0000 000000 0
BDC Capital Growth/Expansion Minority 000 0000 000000 0
DCVC Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »